Search Within

Deaglan Joseph McHugh

Formats
  1. Meeting Abstract (24)
  2. Journal Article (18)
  3. Correspondence (1)
  4. Editorial (1)
  5. Review (1)
Groups
  1. Department of Medicine (45)
  2. Genitourinary Oncology Service (45)
  3. Solid Tumor Oncology Division (45)
  4. Weinberg Fellows (32)
  5. Epidemiology and Biostatistics (21)
  6. Survivorship Research (21)

More Groups

People
  1. Darren Feldman (28)
  2. Samuel Funt (25)
  3. Andrea Knezevic (21)
  4. Dean Bajorin (21)
  5. Robert Motzer (20)
  6. George Bosl (13)

More People

Years
  1. 2025 (5)
  2. 2024 (9)
  3. 2023 (4)
  4. 2022 (6)
  5. 2021 (7)
  6. 2020 (4)

More Years

Publications
  1. Journal of Clinical Oncology (28)
  2. Annals of Oncology (2)
  3. Cancer (2)
  4. Clinical Genitourinary Cancer (2)
  5. Advances in Urology (1)
  6. American Society of Clinical Oncology Educational Book (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (29)
  2. Oxford University Press (3)
  3. Elsevier Inc. (2)
  4. Wiley Blackwell (2)
  5. American Medical Association (1)
  6. Elsevier BV (1)

More Publishers

Results (45)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Identifying germline genetic alterations or environmental factors associated with bilateral germ cell tumor (GCT)
    Meeting Abstract

    Gleeson, J. P.; Harrold, E.; Bromberg, M.; Patel, Z.; Knezevic, A.; Thomas, T.; Ravichandran, V.; Tran, C.; Silber, D.; Carver, B. S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase II trial of cabozantinib plus nivolumab in patients with non-clear-cell renal cell carcinoma and genomic correlates
    Journal Article

    Lee, C. H.; Voss, M. H.; Carlo, M. I.; Chen, Y. B.; Zucker, M.; Knezevic, A.; Lefkowitz, R. A.; Shapnik, N.; Dadoun, C.; Reznik, E.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase II study of talazoparib and avelumab in VHL deficient clear cell renal cell carcinoma
    Meeting Abstract

    Kotecha, R.; Lee, C. H.; McHugh, D. J.; Dadoun, C.; Knezevic, A.; Carlo, M. I.; Feld, E.; Shapnik, N.; Shah, N. J.; Feldman, D. R.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Neoadjuvant atezolizumab with gemcitabine and cisplatin in patients with muscle-invasive bladder cancer: A multicenter, single-arm, phase II trial
    Journal Article

    Funt, S. A.; Lattanzi, M.; Whiting, K.; Al-Ahmadie, H.; Quinlan, C.; Teo, M. Y.; Lee, C. H.; Aggen, D.; Zimmerman, D.; McHugh, D.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Outcomes after multidisciplinary management of primary mediastinal germ cell tumors
    Journal Article

    Caso, R.; Jones, G. D.; Bains, M. S.; Hsu, M.; Tan, K. S.; Feldman, D. R.; Funt, S. A.; Reuter, V. E.; Bosl, G. J.; McHugh, D.; more...
    Annals of Surgery (2021)

    Fulltext@MSK | Save
  • Immunity to childhood vaccines following high dose chemotherapy (HDCT) and autologous stem cell transplantation (ASCT) for germ cell tumors (GCT) with comparison to Hodgkin lymphoma (HL)
    Meeting Abstract

    Feldman, D. R.; Lewis, A. R.; Knezevic, A.; Ali, D.; Bromberg, M.; Aronson, J.; Funt, S. A.; McHugh, D. J.; Motzer, R. J.; Bajorin, D. F.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Nivolumab plus cabozantinib in patients with non-clear cell renal cell carcinoma: Results of a phase 2 trial
    Meeting Abstract

    Lee, C. H.; Voss, M. H.; Carlo, M. I.; Chen, Y. B.; Reznik, E.; Knezevic, A.; Lefkowitz, R. A.; Shapnik, N.; Tassone, D.; Dadoun, C.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A phase II, nonrandomized open trial assessing pain efficacy with radium-223 in symptomatic metastatic castration-resistant prostate cancer
    Journal Article

    McHugh, D.; Tagawa, S.; Moryl, N.; Milowsky, M.; Heller, G.; Osborne, J.; Rathkopf, D.; Basch, E.; Pandit-Taskar, N.; Morris, M. J.
    Clinical Genitourinary Cancer (2021)

    Fulltext@MSK | Save
  • Four cycles of etoposide plus cisplatin for patients with good-risk advanced germ cell tumors
    Journal Article

    Funt, S. A.; McHugh, D. J.; Tsai, S.; Knezevic, A.; O'Donnell, D.; Patil, S.; Silber, D.; Bromberg, M.; Carousso, M.; Reuter, V. E.; more...
    The Oncologist (2021)

    Fulltext@MSK | Save
  • Enfortumab vedotin in FGFR3-mutated advanced urothelial carcinoma
    Meeting Abstract

    Teo, M. Y.; Ratna, N.; Regazzi, A. M.; Zimmerman, D. E.; McHugh, D. J.; Laccetti, A. L.; Xiao, H.; Lee, C. H.; Aggen, D. H.; Funt, S. A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save